Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Sodium–Glucose Cotransporter-2 Inhibitors as Adjunctive Therapy to Automated Insulin Delivery System in Type 1 Diabetes: A Systematic Review and

SGLT-2i, DPP-4i, and GLP-1 RA may serve as effective and safe adjuncts for T1D individuals using AID systems, offering improvements in TIR, reductions in hyperglycemia, and reduced insulin requirements without evidence of increasing DKA and SH.